COVID-19 Timeline: February 2021

January 13, 2022

At Bioethics.com we have kept up with the spread of COVID-19 and the related bioethical questions that this pandemic brings. The posts that follow highlights news from February 2021 and were originally posted at Bioethics.com. These posts focus on the bioethical issues that medical professionals, bioethicists, public health officials, and scientists grappled with as SARS-CoV-2 swept the globe.

February 1: “COVID-19: Novavax Jab ‘Effective Against UK Variant’” by Nicky Broyd, Medscape

The MHRA is continuing its rolling assessment of the coronavirus vaccine from the US drug company Novavax after the company reported it was effective against the UK variant with an overall efficacy of 89.3%. The phase 3 UK trial in collaboration with the National Institute for Health Research (NIHR) vaccine registry involved 15,000 participants aged 18-84, with 27% aged over 65. There were 62 positive cases, 56 of them in the placebo group. Half the cases were the UK variant of the virus.

February 1: “J&J Vaccine 85% Efficacious Against Severe COVID Globally” by Damian McNamara, Medscape 

The Janssen/Johnson & Johnson single-dose adenovirus vaccine provides 85% efficacy globally against severe COVID-19 illness, and it is 72% efficacious against moderate-to-severe illness in the US, according to highly anticipated interim Phase 3 results announced this morning.

February 1: “Additional Covid-19 Vaccines Bring Choices–and Complications–to the Rollout” by Andrew Joseph and Olivia Goldhill, STAT News

It’s always good for consumers to have options, right? And indeed, the United States should soon have three Covid-19 vaccines being injected into people’s arms, with more potentially on the way in the coming months, accelerating the race to vaccinate hundreds of millions of people as quickly as possible. But all vaccines are not equal, and increasingly, health authorities and providers will be dealing with shots with varying attributes: different storage requirements, efficacy, dosing regimens, and manufacturing platforms.

February 1: “Older Adults Without Family or Friends Lag in Race to Get Vaccines” by Judith Graham, Kaiser Health News

A divide between “haves” and “have-nots” is emerging as older adults across the country struggle to get covid-19 vaccines. Seniors with family members or friends to help them are getting vaccine appointments, even if it takes days to secure them. Those without reliable social supports are missing out.

February 2: “The Sputnik V Vaccine and Russia’s Race to Immunity” by Joshua Yaffa, The New Yorker

In fact, Russian scientists hadn’t published any data from their Phase I and Phase II trials, which test a vaccine’s safety and potential for efficacy among a limited number of volunteers, and hadn’t even started Phase III, which tests the vaccine in a much larger group of volunteers, using a placebo as a control. Still, Sputnik V had already begun to make its way through Russian society.

February 2: “Covid Deaths Are Starting to Drop in Every Part of the U.S.” by Jonathan Levin, Bloomberg

Covid-19 deaths have begun to decline in every section of the U.S., the latest sign of relief as cases continue to drop and the vaccination push accelerates. The virus has been receding in the U.S. for about three weeks, but reported deaths — the lagging indicator that’s the ultimate measure of Covid’s impact — had remained near record levels.

February 2: “Why Are So Many Health-Care Workers Resisting the COVID Vaccine?” by Dhruv Khullar, The New Yorker

Despite confronting the damage of COVID-19 firsthand—and doing work that puts them and their families at high risk—health-care workers express similar levels of vaccine hesitancy as people in the general population. Recent surveys suggest that, over all, around a third of health-care workers are reluctant to get vaccinated against COVID-19.

February 3: “COVID-19 Virus May Prompt Body to Attack Itself” by Brenda Goodman, Medscape

An international team of researchers studying COVID-19 has made a startling and pivotal discovery: The virus appears to cause the body to make weapons to attack its own tissues. The finding could unlock a number of COVID’s clinical mysteries.

February 3: “Novavax and J&J COVID-19 Vaccines Are Effective, But the Virus Variant from South Africa Poses Problems” by Ryan Cross, Chemical & Engineering News 

The Novavax shots were only 60% effective in South Africa, and the J&J vaccine only 57% effective in that country. Both companies found that more than 90% of the people who tested positive for COVID-19 and had their virus samples sequenced were infected with the B.1.351 variant, supporting the growing concern that some new variants of the virus could hinder the effectiveness of the vaccines.

February 3: “New Vaccine Puzzle: Who Should Get Which Shot?” by Benjamin Mueller and Rebecca Robins, The New York Times

First came the good news. The European Union authorized a third vaccine. Then, the bad news. Regulators in country after country suggested restricting it to younger people until more testing was done. The decisions marked the start of a delicate new phase of vaccination drives, one in which a growing menu of coronavirus vaccines was accompanied by contentious debates about who should be given which shots.

February 3: “In the Vaccine Scramble, Cancer Patients Are Left Behind” by Dani Blum, The New York Times

Facing conflicting guidance and logistical chaos, many cancer patients are struggling to navigate the bumpy rollout of the Covid-19 vaccination campaign. Ideally, cancer patients who take immunosuppressant medications should receive vaccinations under the care of a doctor, or in a cancer center, where they can be closely monitored and encounter fewer people than they would at a mass distribution site. But the limited availability of the vaccine, plus the havoc and confusion surrounding the rollout, leaves patients grasping for answers.

February 4: “Physicians Face Potential Peril with Leftover Vaccine Doses” by Marcia Frellick, Medscape

A Texas judge last week dismissed a theft charge against an emergency medicine physician recently fired from his public health job after he gave leftover COVID-19 vaccine doses to people he knew–highlighting the difficult position many clinicians find themselves in when there are unused doses but no one is on hand to administer them to and the clock is ticking.

February 4: “COVID-19: Antibodies ‘Remain for at Least 6 Months’” by Peter Russell, Medscape

A study has found that 99% of people who tested positive for SARS-CoV-2 retained antibodies to the virus for 3 months after infection. Researchers at UK Biobank found that 87.8% remained seropositive for the full 6 months that the study lasted. The discovery indicated that the antibodies produced following natural infection may provide a degree of protection for most people, scientists said.

February 4: “New COVID-19 Monoclonal Antibody Data Could Shift Clinical Practice” by Eleanor Cummins, Medscape

New data from phase 3 trials of monoclonal antibodies for patients with recent COVID-19 diagnoses, or at high risk for SARS-CoV-2 infection, could move the needle on clinician acceptance of the treatments, experts say.

February 4: “Exclusive: Indigenous Americans Dying from Covid at Twice the Rate of White Americans” by Nina Lakhani, The Guardian

Covid is killing Native Americans at a faster rate than any other community in the United States, shocking new figures reveal. American Indians and Alaskan Natives are dying at almost twice the rate of white Americans, according to analysis by APM Research Lab shared exclusively with the Guardian.

February 4: “With a Seductive Number, AstraZeneca Study Fueled Hopes That Eclipsed Its Data” by Matthew Herper and Helen Branswell, STAT News

Media reports seized on a reference in the paper from Oxford researchers that a single dose of the vaccine cut positive test results by 67%, pointing to it as the first evidence that a vaccine could prevent transmission of the virus. But the paper, which has not yet been peer-reviewed, does not prove or even claim that — although it hints at the possibility.

February 4: “‘Cruel’ Digital Race for Vaccines Leaves Many Seniors Behind” by Will Stone, Kaiser Health News

With millions of older Americans eligible for covid-19 vaccines and limited supplies, many continue to describe a frantic and frustrating search to secure a shot, beset by uncertainty and difficulty. The efforts to vaccinate people 65 and older have strained under the enormous demand that has overwhelmed cumbersome, inconsistent scheduling systems.

February 4: “Could Mixing COVID Vaccines Boost Immune Response” by Heidi Ledford, Nature

Researchers in the United Kingdom have launched a study that will mix and match two COVID-19 vaccines in a bid to ease the daunting logistics of immunizing millions of people — and potentially boost immune responses in the process.

February 5: “States Shift COVID Vaccine from Long-Term Care to General Public” by Alicia Ault, Medscape

Some states have started taking COVID-19 vaccine from allocations meant for long-term care facilities and offering it to the general public in order to more quickly vaccinate more residents, according to state health officials.

February 5: “Coronavirus Cases Drop at US Homes for Elderly and Infirm” by Jay Reeves, Associated Press

Coronavirus cases have dropped at U.S. nursing homes and other long-term care facilities over the past few weeks, offering a glimmer of hope that health officials attribute to the start of vaccinations, an easing of the post-holiday surge and better prevention, among other reasons.

February 8: “Why the U.S. Is Underestimating Covid Reinfection” by JoNel Aleccia, Kaiser Health News

As millions of Americans struggle to recover from covid and millions more scramble for the protection offered by vaccines, U.S. health officials may be overlooking an unsettling subgroup of survivors: those who get infected more than once.

February 8: “WHO Warns Against Dismissing AstraZeneca Vaccine after Setbacks” Medical Xpress

The World Health Organization and its Covax partners cautioned Monday against dismissing AstraZeneca’s COVID vaccine after several setbacks, insisting it remained an important, life-saving tool. The AstraZeneca vaccine is currently a vital part of Covax, which was set up to procure COVID-19 vaccines and ensure their equitable distribution around the world.

February 8: “New Variants Raise Worry About COVID-19 Virus Reinfections” by Marilyn Marchione, Associated Press

Evidence is mounting that having COVID-19 may not protect against getting infected again with some of the new variants. People also can get second infections with earlier versions of the coronavirus if they mounted a weak defense the first time, new research suggests. How long immunity lasts from natural infection is one of the big questions in the pandemic.

February 9: “US FDA Gearing Up for Rapid Review of Potential COVID-19 Booster Shots” by Reuters Staff, re-published on Medscape

The U.S. Food and Drug Administration is planning a rapid review process for quick turnaround of new COVID-19 booster shots if variants of the coronavirus emerge against which the vaccines do not provide protection, the agency’s top official said on Thursday.

February 9: “‘The Death Market’: Oxygen Shortage Leaves Mexicans to Die at Home” by Natalie Kitroeff and Oscar Lopez, The New York Times

After surviving his own bout with the coronavirus and then losing his job, Mr. Hernández began selling oxygen tanks out of his car. Then a second wave of the coronavirus slammed into Mexico this winter and demand for oxygen exploded, spawning a national shortage of devices that deliver the lifesaving resource. Prices spiked. A black market metastasized.

February 9: “Covid-19 Vaccine Scams Spread Under Facebook and Telegram’s Watch” by Brian Barrett, Wired

Scammers have flooded Facebook and other social media platforms with Covid-19 scams for almost as long as the disease has had a name. Now, as desperation builds for access to a limited vaccine supply, internet charlatans have escalated in kind, offering shipments of doses in Facebook groups and Telegram chats.

February 9: “US Vaccine Drive Complicated by 1st, 2nd Dose Juggling Act” by Candice Choi and Marion Renault, Associated Press

The U.S. has entered a tricky phase of the COVID-19 vaccination effort as providers try to ramp up the number of people getting first shots while also ensuring a growing number of others get second doses just when millions more Americans are becoming eligible to receive vaccines. The need to give each person two doses a few weeks apart vastly complicates the country’s biggest-ever vaccination campaign.

February 10: “Pandemic-Fueled Alcohol Abuse Creates Wave of Hospitalizations for Liver Disease” by Eli Cahan, Kaiser Health News

As the pandemic sends thousands of recovering alcoholics into relapse, hospitals across the country have reported dramatic increases in alcohol-related admissions for critical diseases like alcoholic hepatitis and liver failure.

February 10: “In Switch, South Africa to Give Health Workers J&J Vaccine” By Andrew Meldrum, Associated Press

South Africa will start vaccinating front-line health workers next week with a shot that is still in testing — an unorthodox strategy announced Wednesday after officials abandoned plans to use another vaccine that a small study suggests is only minimally effective against the variant dominant in the country.

February 11: “FDA Grants Emergency Use to Monoclonal Antibody Combo for COVID” by Damian McNamara, Medscape

The US Food and Drug Administration (FDA) has granted emergency use authorization (EUA) to two monoclonal antibodies in combination for mild-to-moderate COVID-19 for people 12 years and older who test positive. Bamlanivimab and etesevimab (both Eli Lilly) are authorized to treat people with elevated risk for severe disease, including adults over 65 and those with relevant comorbidities

February 11: “Covid-19 Vaccination Rates Follow the Money in States with the Biggest Wealth Gaps, Analysis Shows” by Olivia Goldhill, STAT News

The findings back up, with hard data, anecdotal reports from around the country that wealthy people have been able to gain access to vaccines ahead of low-income people.

February 11: “COVID Deaths in Africa Jump 40% in One Month: WHO” by Medical Xpress

Deaths from COVID-19 in Africa surged by 40 percent over the last month, the World Health Organisation said Thursday, as the continent’s toll approaches 100,000.

February 11: “Pfizer Vaccine Found to Give Strong Immune Response to New Covid Variants” by Lina Geddes, The Guardian

People who have received two doses of the Pfizer vaccine have been found to have strong T-cell responses against the Kent and South African variants of Covid, suggesting that the vaccine will continue to protect against serious disease in the coming months. In the first study to test immune responses against the variants circulating in populations, researchers found that although antibody responses against the new variants were blunted, they may still be high enough to protect most people from becoming infected, after a second dose of vaccine has been given.

February 11: “The Newest Diplomatic Currency: Covid-19 Vaccines” by Mujib Mashal and Vivian Yee, The New York Times

The coronavirus vaccine — one of the world’s most in-demand commodities — has become a new currency for international diplomacy. Countries with the means or the know-how are using the shots to curry favor or thaw frosty relations.

February 12: “Vaccine Delay in North Macedonia Stirs Political Tension” by Konstantin Testorides and Dusan Stojanovic, Associated Press

As its neighbors boast of progress in their vaccination programs, North Macedonia is still waiting to deliver its first shot — adding political tension to the tiny nation’s pandemic health crisis, and highlighting difficulties that some countries bordering the European Union are facing.

February 12: “‘An Existential Threat’: Disabled and Chronically Ill Californians Criticize Vaccine Policy” by Maanvi Singh, The Guardian

Disabled and chronically ill Californians say that the state’s coronavirus vaccine distribution is leaving them in the lurch, as the death toll in the country’s most populous state continues to climb. California abruptly announced last month that it was changing its vaccination policies to prioritize age, rather than underlying risk, in deciding who will get the inoculation next.

February 12: “Lack of Covid Data on People with Intellectual Disabilities ‘Comes with a Body Count’” by Katheryn Houghton, Kaiser Health News

Early studies have shown that people with intellectual and developmental disabilities have a higher likelihood of dying from the virus than those without disabilities, likely because of a higher prevalence of preexisting conditions.

February 15: “You Think the U.S. Has Vaccine Issues? 130 Countries Haven’t Even Started Vaccinating” by Jason Beaubien, NPR

In some countries, citizens are grumbling about the inefficient rollout of COVID-19 vaccines. It’s unclear exactly when doses will be available. Websites for appointments keep crashing. Lines are long. And then there are the 130 countries that “are yet to administer a single dose,” according to UNICEF. That’s 2.5 billion people who so far have been completely shut out of the global vaccine campaign. Many of these low- and middle-income countries are urgently shopping for vaccines.

February 16: “North Korea Accused of Hacking Pfizer for Covid-19 Vaccine Data” by BBC

North Korea attempted to steal Covid-19 vaccine technology from US pharmaceutical company Pfizer, according to South Korean intelligence officials.

February 16: “What We Know About the Impact of Covid-19 on Children” by Jason Gale, Bloomberg

Young children typically are “superspreaders” of respiratory germs, so it’s puzzling that they don’t seem to be major transmitters of the coronavirus that causes Covid-19. They’re also relatively absent among hospitalized patients.

February 16: “To Get Their Lives Back, Teens Volunteer for Vaccine Trials” by Jan Hoffman, The New York Times

To reach students, some researchers have tapped school connections, local pediatricians and social media campaigns. While waiting for appointments in the vaccine research clinics, some teenagers, ignoring advice to keep their vaccine volunteering off of social media, have posted TikTok videos, which have inspired friends to sign up.

February 17: “Crippling Weather Hampers Vaccine Deliveries, Distribution” by Suman Naishadham and Jocelyn Noveck, Associated Press

The icy blast across much of the U.S. injected more confusion and frustration into the nation’s COVID-19 vaccination drive Wednesday just when it was gathering speed, snarling vaccine deliveries and forcing the cancellation of countless shots around the country.

February 17: “Up to 90 Volunteers in UK to Take Part in Pioneering Covid Infection Trial” by Nicola Davis, The Guardian

The world’s first coronavirus human challenge study will begin in the UK in a matter of weeks, following approval from the country’s clinical trials ethics body, the business department said. Approval has been given for an initial trial that will involve up to 90 carefully screened, healthy, adult volunteers aged between 18 and 30.

February 17: “Coronavirus Vaccine Nears Final Tests in Cuba. Tourists May Be Inoculated.” by Ed Augustin and Natalie Kitroeff, The New York Times

People wait in line for four hours to buy detergent in Havana. Cuban pharmacies are out of pain medication. There are national bread shortages. And yet the Cuban government says it is on the brink of an extraordinary scientific achievement: the mass production of a coronavirus vaccine invented on the island.

February 19: “New Data Boost Calls for Single COVID-19 Vaccine Dose” by Damian McNamara, Medscape

A single dose of the Pfizer/BioNTech vaccine offers 92.6% efficacy in new calculations based on data submitted to the US Food and Drug Administration (FDA), researchers report. Together with previous findings that a single Moderna vaccine dose provides 92.1% efficacy against SARS-CoV-2 infection, investigators propose it is time to defer the second dose to extend protection to more people through single-dose mRNA vaccinations.

February 19: “U.S. Life Expectancy Fell by One Year in 2020, CDC Data Show” by Manas Mishra and Vishwadha Chander, Reuters

Life expectancy in the United States fell by a year in the first half of 2020 – the biggest decline since World War 2 – and stood at the lowest levels since 2006, according to estimates issued by the U.S. Centers for Disease Control and Prevention (CDC) on Thursday.

February 19: “Hundreds of Thousands of COVID-19 Vaccine Deliveries, Injections Delayed by Winter Storm” by Karen Brooks Harper, Texas Tribune

The winter storm has halted Texas’ urgent and critical COVID-19 vaccination efforts — delaying the delivery of hundreds of thousands of doses that were scheduled to arrive and preventing what might have been 1 million injections by hundreds of providers this week, state health officials said Tuesday.

February 19: “The Philippines Has Vaccinated Zero Health-Care Workers So Far” by Julie McCarthy, NPR

In fact, as of this week, not a single health worker in the Philippines has been vaccinated. And the fear and anxiety among these workers has led more than a few to take a leave or quit their jobs during this public health crisis, according to colleagues.

February 22: “Price Check: Nations Pay Wildly Different Prices for Vaccines” by Jason Beaubien, NPR

While nearly 60 million doses of COVID vaccine have been administered in the United States, most nations in the world have vaccinated hardly anyone.

February 22: “People Who Have Had Covid Should Get Single Vaccine Dose, Studies Suggest” by Apoorva Mandavilli, The New York Times

Nearly 30 million people in the United States — and probably many others whose illnesses were never diagnosed — have been infected with the coronavirus so far. Should these people still be vaccinated? Two new studies answer that question with an emphatic yes. In fact, the research suggests that for these people just one dose of the vaccine is enough to turbocharge their antibodies and destroy the coronavirus — and even some more infectious variants.

February 22: “Long-Term Studies of COVID-19 Vaccines Hurt by Placebo Recipients Getting Immunized” by Richard Harris, NPR

Tens of thousands of people who volunteered to be in studies of the Pfizer-BioNTech and Moderna COVID-19 vaccines are still participating in follow-up research. But some key questions won’t be easily answered, because many people who had been in the placebo group have now opted to take the vaccine.

February 22: “A Leaked Report Shows Pfizer’s Vaccine Is Conquering Covid-19 in Its Largest Real-World Test” by Joshua Mitnick & Antonio Regalado, MIT Technology Review

A leaked scientific report jointly prepared by Israel’s health ministry and Pfizer claims that the company’s covid-19 vaccine is stopping nine out of 10 infections and the country could approach herd immunity by next month. The study, based on the health records of hundreds of thousands of Israelis, finds that the vaccine may sharply curtail transmission of the coronavirus.

February 22: “Covid-19 Vaccinations Cut Hospitalizations and Deaths, U.K. Finds” by Jason Douglas and Max Colchester, The Wall Street Journal

The U.K.’s rollout of Pfizer Inc. and BioNTech SE’s Covid-19 vaccine has led to a substantial drop in infections in people 80 and over, according to preliminary data that adds to a growing body of evidence that the shots provide significant if not complete protection against the disease.

February 22: “Declining a Covid-19 Vaccine Risks Penalties in Some Countries” by Dasl Yoon, The Wall Street Journal

Some countries are sharpening their Covid-19 vaccination pitches to the public: Get a shot or face a potential penalty.

February 23: “Organ Transplant Patient Dies After Receiving Covid-Infected Lungs” by JoNel Aleccia, Kaiser Health News

Doctors say a woman in Michigan contracted covid-19 and died last fall two months after receiving a tainted double-lung transplant from a donor who turned out to harbor the virus that causes the disease — despite showing no signs of illness and initially testing negative.

February 23: “Vaccines Adapted for Variants Will Not Need Lengthy Testing, F.D.A. Says” by Noah Weiland, Katie Thomas, and Carl Zimmen, The New York Times

The Food and Drug Administration said on Monday that vaccine developers would not need to conduct lengthy randomized controlled trials for vaccines that have been adapted to protect against concerning coronavirus variants.

February 23: “Why the Johnson & Johnson Vaccine Has Gotten a Bad Rap–And Why That’s Not Fair” by Ari Shapiro, NPR

Two COVID-19 vaccines are being distributed in the U.S. right now, and this week an FDA advisory committee will vote on whether a third should join them. If granted emergency use authorization, Johnson & Johnson’s one-dose vaccine would become available in the U.S., along with those from Pfizer and Moderna.

February 24: “Where a Vaccination Campaign Faces Skepticism, War and Corruption” by David Zucchino and Najim Rahim, The New York Times

Afghanistan, whose citizens have largely brushed aside the coronavirus pandemic as exaggerated or an outright hoax, is now preparing to distribute its first batch of vaccines. A half-million doses of the AstraZeneca-Oxford vaccine, produced by an Indian manufacturer, were delivered to the capital, Kabul, by India on Feb. 7. But the arrival was greeted with indifference by many Afghans, who have rebuffed government warnings that the virus is a deadly public health threat.

February 24: “‘It Doesn’t Feel Worth It’: Covid Is Pushing New York’s EMT’s to the Brink” by Martha Pskowski, The Guardian, republished at Kaiser Health News

An emergency medical services lieutenant and union leader with the New York City Fire Department, Almojera said he has seen more death in the past year than in his previous decade of work. “We can’t possibly process the traumas, because we’re still in the trauma,” he said.

February 24: “FDA Says Single-Dose Shot from J&J Prevents Severe COVID” by Lauren Neergaard and Matthew Perrone, Associated Press

Johnson & Johnson’s single-dose vaccine offers strong protection against severe COVID-19, according to an analysis released Wednesday by U.S. regulators that sets the stage for a final decision on a new and easier-to-use shot to help tame the pandemic.

February 24: “Ghana 1st Nation to Receive Coronavirus Vaccines from COVAX” by Francis Kokutse and Carley Petesch, Associated Press

Ghana received the world’s first delivery of coronavirus vaccines from the United Nations-backed COVAX initiative on Wednesday — the long-awaited start for a program that has thus far fallen short of hopes that it would ensure shots were given quickly to the world’s most vulnerable people.

February 25: “‘V.I.P Immunization’ for the Powerful and Their Cronies Rattles South America” by Mitra Taj, Anatoly Kurmanaev, Manuela Andreoni, and Daniel Politi, The New York Times

The hope brought by the arrival of the first vaccines in South America is hardening into anger as inoculation campaigns have spiraled into scandal, cronyism and corruption, rocking national governments and sapping trust in the political establishment.

February 25: “Covid Vaccine Websites Violate Disability Laws, Create Inequality for the Blind” by Lauren Weber and Hannah Recht, Kaiser Health News

Many covid vaccination registration and information websites at the federal, state and local levels violate disability rights laws, hindering the ability of blind people to sign up for a potentially lifesaving vaccine, a KHN investigation has found.

February 25: “Medical Oxygen Scarce in Africa, Latin America Amid Virus” by Carley Petesch and Lori Hinnant, Associated Press

A crisis over the supply of medical oxygen for coronavirus patients has struck nations in Africa and Latin America, where warnings went unheeded at the start of the pandemic and doctors say the shortage has led to unnecessary deaths.

February 25: “We Still Don’t Know How Well Covid Vaccines Stop Transmission” by Megan Moteni, Wired

In the interim, an increasing number of people will find themselves in a liminal state, navigating what it means to be a vaccinated person moving through an unvaccinated world. What are its rules, and what will it take to be a good citizen of it?

February 26: “Scotland’s Vaccine Rollout Suggests Delaying the 2nd COVID-19 Shot Is a Bad Idea” by Andrew Dunn, Business Insider

The UK’s strategy of delaying second coronavirus vaccine doses up to 12 weeks to give more people a first shot may carry serious risk. On Monday, Scottish researchers released data from their vaccination campaign, including more than 1 million people who’ve been immunized, that suggests protection from a single dose peaks and then declines after about five weeks.

February 26: “As Covid-19 Vaccine Distribution Widens, Inequality Lingers” by Michael Schulson, Undark

On Wednesday, a plane carrying 600,000 doses of the AstraZeneca Covid-19 vaccine landed in Accra, Ghana, marking the first global shipment in a plan to deliver 2 billion doses of Covid-19 vaccine, mostly to lower- and middle-income countries, in 2021. The news comes as the global Covid-19 vaccine pool grows, due to increased manufacturing capacity and new vaccines. But, despite that growth, countries continue to jostle for access to the coveted shots.

Return to Timeline

Posted by

Posted in , Covid-19